Safety & Efficacy of IR-101 in Relapsed/Refractory Neuroblastoma
Clinical trial NCT07067346 · RECRUITING
Trial details
- NCT number
- NCT07067346
- Sponsor
- Sichuan University
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-18
- Primary completion
- 2026-06-30
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.